Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies

Ultrasound in Obstetrics and Gynecology

Volumn 45, Issue 3, 2015, Pages 286-293

  Droge L ^a   Herraiz, I ^b   Zeisler, H ^c   Schlembach, D ^d   Stepan, H ^e   Kussel L ^c   Henrich, W ^a   Galindo, A ^b   Verlohren, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiogenic factors; Multiple pregnancy; PlGF; Pre eclampsia; SFlt 1; Twins

Indexed keywords

BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; EUROPE; FEMALE; HUMAN; MULTICENTER STUDY; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TWIN PREGNANCY;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; EUROPE; FEMALE; HUMANS; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; PREGNANCY, TWIN; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84923922469     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14760     Document Type: Article

References (32)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799.
2. World Health Organization. The World Health Report 2005. Make every mother and child count. http://www.who.int/ whr/2005/en [Accessed September 23 2014].
3. Ngoc NT, Merialdi M, Abdel-Aleem H, Carroli G, Purwar M, Zavaleta N, Campódonico L, Ali MM, Hofmeyr GJ, Mathai M, Lincetto O, Villar J. Causes of stillbirths and early neonatal deaths: Data from 7993 pregnancies in six developing countries. Bull World Health Organ 2006; 84: 699-705.
4. Friedman SA, Schiff E, Kao L, Sibai BM. Neonatal outcome after preterm delivery for pre-eclampsia. Am J Obstet Gynecol 1995; 172: 1785-1788; discussion 1788-1792.
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contriubute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
6. Powe CE, Levine RJ, Karumanchi SA. Pre-eclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856-2869.
7. Roberts JM, Hubel CA. The two stage model of preeclampsia: Variations on the theme. Placenta 2009; 30 (Suppl A): S32-S37.
8. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med 2004; 350: 672-683.
9. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005.
10. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012; 125: 911-919.
11. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9-23.
12. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of pre-eclampsia. Am J Obstet Gynecol 2010; 202: 161.e1-11.
13. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in pre-eclamptic patients. Am J Obstet Gynecol 2012; 206: 58.e1-8.
14. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J,Markfeld-Erol F, Galindo A, Schoofs K, Denk B, Stepan H. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 2014; 63: 346-352.
15. Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, VanDorsten JP, Landon M, Miodovnik M, Paul R, Meis P, Thurnau G, Dombrowski M, Roberts J, McNellis D. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182: 938-942.
16. Santema JG, Koppelaar I, Wallenburg HC. Hypertensive disorders in twin pregnancy. Eur J Obstet Gynecol Reprod Biol 1995; 58: 9-13.
17. Chauhan SP, Scardo JA, Hayes E, Abuhamad AZ, Berghella V. Twins: Prevalence, problems, and preterm births. Am J Obstet Gynecol 2010; 203: 305-315.
18. Fox NS, Roman AS, Saltzman DH, Hourizadeh T, Hastings J, Rebarber A. Risk factors for pre-eclampsia in twin pregnancies. Am J Perinatol 2014; 31: 163-166.
19. Ananth CV, Chauhan SP. Epidemiology of twinning in developed countries. Semin Perinatol 2012; 36: 156-161.
20. Prapas N, Kalogiannidis I, Prapas I, Xiromeritis P, Karagiannidis A, Makedos G. Twin gestation in older women: Antepartum, intrapartum complications, and perinatal outcomes. Arch Gynecol Obstet 2006; 273: 293-297.
21. Simchen MJ, Shulman A, Wiser A, Zilberberg E, Schiff E. The aged uterus: Multifetal pregnancy outcome after ovum donation in older women. Hum Reprod 2009; 24: 2500-2503.
22. Lu?covnik M, Tul N, Verdenik I, Novak Z, Blickstein I. Risk factors for pre-eclampsia in twin pregnancies: A population-based matched case-control study. J Perinat Med 2012; 40: 379-382.
23. Rana S, Hacker MR, Modest AM, Salahuddin S, Lim KH, Verlohren S, Perschel FH, Karumanchi SA. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected pre-eclampsia. Hypertension 2012; 60: 451-458.
24. Sánchez O, Llurba E, Marsal G, Domínguez C, Aulesa C, Sánchez-Durán MA, Goya MM, Alijotas-Reig J, Carreras E, Cabero L. First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: Relationship with assisted reproduction technology. Hum Reprod 2012; 27: 358-365.
25. Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA. Twin pregnancy and the risk of preeclampsia: Bigger placenta or relative ischemia? Am J Obstet Gynecol 2008; 198: 428.e1-6.
26. Ruiz-Sacedón N, Perales-Puchalt A, Borras D, Gómez R, Perales A. Angiogenic growth factors in maternal and fetal serum in concordant and discordant twin pregnancies. J Matern Fetal Neonatal Med 2014; 27: 870-873.
27. Nevo O, Many A, Xu J, Kingdom J, Piccoli E, Zamudio S, Post M, Bocking A, Todros T, Caniggia I. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2008; 93: 285-292.
28. Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network. Soluble fms-Like tyrosine kinase (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PloS One 2010; 5: E13263.
29. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
30. Engels T, Pape J, Schoofs K, Henrich W, Verlohren S. Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders. Hypertens Pregnancy 2013; 32: 459-473.
31. Cowans NJ, Spencer K. First trimester maternal serum placental growth factor levels in twin pregnancies. Prenat Diagn 2013; 33: 1260-1263.
32. Zhang WH, Alexander S, Bouvier-Colle MH, Macfarlane A; MOMS-B Group. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: The MOMS-B survey. BJOG 2005; 112: 89-96.